Araadenosine
Brand names,
Araadenosine
Analogs
Araadenosine
Brand Names Mixture
Araadenosine
Chemical_Formula
C10H15N5O5
Araadenosine
RX_link
http://www.rxlist.com/cgi/generic3/vidarabine.htm
Araadenosine
fda sheet
Araadenosine
msds (material safety sheet)
Araadenosine
Synthesis Reference
No information avaliable
Araadenosine
Molecular Weight
285.257 g/mol
Araadenosine
Melting Point
No information avaliable
Araadenosine
H2O Solubility
No information avaliable
Araadenosine
State
Solid
Araadenosine
LogP
-2.115
Araadenosine
Dosage Forms
No information avaliable
Araadenosine
Indication
For treatment of chickenpox - varicella, herpes zoster and herpes simplex
Araadenosine
Pharmacology
Vidarabine is a synthetic purine nucleoside analogue with in vitro and in vivo inhibitory activity against herpes simplex virus types 1 (HSV-1), 2 (HSV-2), and varicella-zoster virus (VZV). The inhibitory activity of Vidarabine is highly selective due to its affinity for the enzyme thymidine kinase (TK) encoded by HSV and VZV. This viral enzyme converts Vidarabine into Vidarabine monophosphate, a nucleotide analogue. The monophosphate is further converted into diphosphate by cellular guanylate kinase and into triphosphate by a number of cellular enzymes. in vitro, Vidarabine triphosphate stops replication of herpes viral DNA. When used as a substrate for viral DNA polymerase, Vidarabine triphosphate competitively inhibits dATP leading to the formation of 'faulty' DNA. This is where Vidarabine triphosphate is incorporated into the DNA strand replacing many of the adenosine bases. This results in the prevention of DNA synthesis, as phosphodiester bridges can longer to be built, destabilizing the strand.
Araadenosine
Absorption
No information avaliable
Araadenosine
side effects and Toxicity
No information avaliable
Araadenosine
Patient Information
No information avaliable
Araadenosine
Organisms Affected
Human Herpes Viruses